Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 2 for:    nct01461837
Previous Study | Return to List | Next Study

Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease (HaploSCD)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by New York Medical College
Sponsor:
Collaborators:
Children's Hospital & Research Center Oakland
Medical College of Wisconsin
Washington University School of Medicine
Tufts Medical Center
University of California, San Francisco
University of California, Los Angeles
Miltenyi Biotec GmbH
Children's Hospital Medical Center, Cincinnati
Ann and Robert H. Lurie Children's Hospital of Chicago
Information provided by (Responsible Party):
Mitchell Cairo, New York Medical College
ClinicalTrials.gov Identifier:
NCT01461837
First received: October 19, 2011
Last updated: September 20, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2018
  Estimated Primary Completion Date: April 2017 (Final data collection date for primary outcome measure)